Tag: TVA Medical
BD acquires TVA Medical, makers of everlinQ endoAVF System
BD (Becton, Dickinson and Company) announced it has completed the acquisition of TVA Medical, a company that develops minimally invasive vascular access solutions...
everlinQ endoAVF receives FDA de novo marketing approval
everlinQ endoAVF System (TVA Medical) is now approved by the US Food and Drug Administration for de novo marketing. This innovative, minimally invasive technology...
New data on quality of life and cost savings for everlinQ...
A recent healthcare analysis shows that a novel, catheter-based endovascular system for creating haemodialysis access offers quality-of-life benefits and cost savings compared to the...
Meta-analysis shows positive experience for endoAVF patients for haemodialysis access
An international meta-analysis of clinical experience in patients who received an endovascular arteriovenous fistula (endoAVF) for haemodialysis access was presented at Leipzig Interventional Course...
TVA Medical receives CE mark for everlinQ 4 endovascular AVF system
TVA Medical’s everlinQ 4 endovascular arteriovenous fistula (AVF) system has received CE mark in the European Union. The technology uses a 4F catheter system...
Twelve-month NEAT trial data promising for everlinQ endoAVF haemodialysis access system
TVA Medical has announced the online publication of positive results from the Novel Endovascular Access Trial (NEAT) evaluating its everlinQ endoAVF system. The 12-month...
TVA Medical presents positive everlinQ endoAVF system results at LINC 2017
TVA Medical has provided clinical updates involving its everlinQ endoAVF system at the 2017 Leipzig Interventional Course (LINC; 24-17 January, Leipzig, Germany).
Scientific data regarding the...
NEAT trial shows six times fewer post-creation interventions with endovascular than...
NEAT (Novel endovascular access trial) data presented at the Vascular Interventional Advances (VIVA) 2016 meeting (18–22 September, Las Vegas, USA) suggest that endovascular arteriovenous...
TVA Medical wins innovation award for minimally invasive haemodialysis access system
The company received the honour for its everlinQ System, a catheter-based technology designed to create haemodialysis access for chronic kidney disease patients in a minimally-invasive procedure.
